Benzinga's Top Downgrades

Analysts at Cowen & Company downgraded

from Outperform to Market Perform. The price target for Catamaran has been raised from $57.00 to $61.50. Catamaran's shares closed at $59.83 yesterday. Analysts at Piper Jaffray downgraded

from Overweight to Neutral. The price target for Auspex Pharmaceuticals has been raised from $91.00 to $101.00. Auspex Pharmaceuticals' shares closed at $100.36 yesterday. Analysts at Imperial Capital downgraded

from Outperform to In-line. The price target for Jones Energy has been lowered from $14.00 to $12.00. Jones Energy shares closed at $8.89 yesterday. Analysts at Wells Fargo downgraded

from Outperform to Market Perform. Schlumberger's shares closed at $84.48 yesterday.